D-Index & Metrics Best Publications

Thomas M. Gress

Philipp University of Marburg
Germany

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name Citations Publications World Ranking National Ranking

Medicine D-index 84 Citations 26,337 482 World Ranking 10001 National Ranking 522

Overview

What is he best known for?

The fields of study Thomas M. Gress is best known for:

Gene
Cancer
Enzyme

His Internal medicine study frequently intersects with other fields, such as Immunohistochemistry. The study of Immunohistochemistry is intertwined with the study of Internal medicine in a number of ways. In his articles, Thomas M. Gress combines various disciplines, including Cancer and Cancer cell. Thomas M. Gress performs multidisciplinary studies into Pancreatic cancer and Pancreatitis in his work. Thomas M. Gress conducts interdisciplinary study in the fields of Pancreatitis and Pancreatic cancer through his research. With his scientific publications, his incorporates both Gene and Gene expression. He frequently studies issues relating to Cell culture and Genetics. He conducts interdisciplinary study in the fields of Cell culture and Gene through his research. Borrowing concepts from Receptor, he weaves in ideas under Biochemistry.

His most cited work include:

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group (1987 citations)
Stromal biology and therapy in pancreatic cancer (627 citations)
Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis (422 citations)

What are the main themes of his work throughout his whole career to date

In general Signal transduction study, his work on Cell biology often relates to the realm of Cancer research, thereby connecting several areas of interest. His Cell biology study frequently draws connections between related disciplines such as Signal transduction. Thomas M. Gress integrates several fields in his works, including Cancer research and Genetics. His study connects Cell culture and Genetics. Among his Internal medicine studies, there is a synthesis of other scientific areas such as Pathology, Gastroenterology, Oncology and Endocrinology. He integrates Pathology and Cancer in his studies. In his research, Thomas M. Gress performs multidisciplinary study on Oncology and Cancer. Thomas M. Gress combines Endocrinology and Internal medicine in his research. He integrates Pancreatic cancer and Pancreas in his studies.

Thomas M. Gress most often published in these fields:

Internal medicine (60.40%)
Cancer (57.72%)
Pancreatic cancer (43.62%)

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Placebo-Controlled, Double-Blind, Prospective, Randomized Study on the Effect of Octreotide LAR in the Control of Tumor Growth in Patients With Metastatic Neuroendocrine Midgut Tumors: A Report From the PROMID Study Group

Anja Rinke;Carmen Schade-Brittinger;Klaus-Jochen Klose;Peter Barth.
Journal of Clinical Oncology (2009)

2838 Citations

International network of cancer genome projects

Thomas J. Hudson;Thomas J. Hudson;Warwick Anderson;Axel Aretz;Anna D. Barker.
(2010)

1839 Citations

Stromal biology and therapy in pancreatic cancer

Albrecht Neesse;Patrick Michl;Kristopher K Frese;Christine Feig.
Gut (2011)

777 Citations

European evidence-based guidelines on pancreatic cystic neoplasms

Marco Del Chiaro;Marc G. Besselink;Lianne Scholten;Marco J. Bruno.
Gut (2018)

774 Citations

Long-term outcomes of autoimmune pancreatitis: a multicentre, international analysis

Phil A. Hart;Terumi Kamisawa;William R. Brugge;Jae Bock Chung.
Gut (2013)

543 Citations

Transforming Growth Factor β1 Treatment Leads to an Epithelial-Mesenchymal Transdifferentiation of Pancreatic Cancer Cells Requiring Extracellular Signal-regulated Kinase 2 Activation

Volker Ellenrieder;Sandra F. Hendler;Wolfgang Boeck;Thomas Seufferlein.
Cancer Research (2001)

489 Citations

Stromal biology and therapy in pancreatic cancer: a changing paradigm

Albrecht Neesse;Hana Algül;David A Tuveson;Thomas M Gress.
Gut (2015)

453 Citations

Chymotrypsin C (CTRC) variants that diminish activity or secretion are associated with chronic pancreatitis.

Jonas Rosendahl;Heiko Witt;Richárd Szmola;Eesh Bhatia.
Nature Genetics (2008)

450 Citations

Genetic profile of 22 pancreatic carcinoma cell lines. Analysis of K-ras, p53, p16 and DPC4/Smad4.

Patrick S. Moore;Bence Sipos;Simonetta Orlandini;Claudio Sorio.
Virchows Archiv (2001)

447 Citations

ENETS Consensus Guidelines for the Management of Patients with Neuroendocrine Neoplasms from the Jejuno-Ileum and the Appendix Including Goblet Cell Carcinomas

Ulrich-Frank Pape;Aurel Perren;Bruno Niederle;David Gross.
Neuroendocrinology (2012)

423 Citations

If you think any of the details on this page are incorrect, let us know.